As of April 16, 2025, I-Mab Biopharma (IMAB) has a market cap of $73.938 million USD. According to our data, I-Mab Biopharma is ranked No.7803 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $73.94 M |
6.73%
|
Dec 31, 2024 | $69.28 M |
-55.26%
|
Dec 29, 2023 | $0.15 B |
-54.55%
|
Dec 30, 2022 | $0.34 B |
-91.18%
|
Dec 31, 2021 | $3.86 B |
0.51%
|
Dec 31, 2020 | $3.84 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
![]() Akeso
9926.HK
|
$9.68 B |
-0.463 B
|
![]() China
|
![]() Legend Biotech
LEGN
|
$6.20 B |
-0.000 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
Market Cap | = | IMAB Stock Price | * | IMAB Shares Outstanding |
= | $0.91 | * | 81.50 M | |
= | $73.94 M |